Based on the work of Ohio State University professor Hiranmoy Das, Rashmivu LLC works in the research and development of stem cell therapies. Das has developed a nanofiber-based ex-vivo human umbilical cord blood-derived stem cell expansion technology, which not only preserves stem cell characteristics, but also provides essential numbers of functional stem cells. Furthermore, the cells can be genetically modified to enhance angiogenic/therapeutic potential for various degenerative diseases such as hind limb ischemia, myocardial ischemia, stroke-mediated ischemia, osteoporosis, Parkinsonâs disease, and wound-healing
